PubMed HealthSearch

SEARCH · PubMed Health

Results for “Portacaval Shunt, Surgical”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies, and review of the literature.

Twenty patients with biopsy proved liver disease, and roentgenologic features of hypertrophic osteoarthropathy have been studied, and the literature has been reviewed. The syndrome is a rare association of many chronic liver diseases, including primary biliary cirrhosis, bile duct carcinoma, benign bile duct stricture, chronic active hepatitis, posthepatitic cirrhosis and alcoholic cirrhosis. Patients may be asymptomatic, although bone pain, arthralgia or arthritis may be presenting symptoms. Ninety per cent of the patients are clinical jaundiced at the time of diagnosis, and 95 per cent have digital clubbing. The distal tibia and fibula are the first bones to become involved, although wrist, foot bones, femurs, hand bones and humeri may be affected in order of frequency. There is no correlation between the presence of esophageal varices or surgical portacaval shunts and the extent of the syndrome, neither is there a correlation with the degree of liver function impairment. Serum calcium and phosphate levels are normal, as is urinary hydroxyproline and estrogen excretion. There was no evidence to implicate elevated levels of growth hormone or overdosage of vitamin A. Although the majority of patients tested had mild arterial hypoxemia, increased cardiac output and evidence of right to left shunting, these were also present in disease-matched control subjects without osteoarthropathy. For screening purposes, patients with chronic liver disease and clubbing should have roentgenologic studies of the lower tibias and fibulas, to select those patients suitable for a more extensive skeletal survey.

Adult

Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Plasma glucagon concentration was elevated 2- to 6-fold in cirrhotic patients with spontaneous portal systemic shunting or surgically induced portacaval anastomosis but was comparable to controls in cirrhotics without portal-systemic shunting. The metabolic clearance rate of glucagon (mol wt 3500) was normal in all of the cirrhotic groups, but the estimated basal systemic delivery rate of glucagon was increased 2- to 6-fold in the hyperglucagonemic patients. The blood glucose response to infusion of glucagon (3 ng per kg per min) was reduced in the cirrhotics with portal-systemic shunting or portacaval anastomosis, and correlated inversely with the delivery rate of endogenous glucagon. Administration of ammonium chloride (3 g) failed to elevate plasma glucagon concentration. It is concluded that hyperglucagonemia in cirrhosis is a consequence of hypersecretion rather than decreased hormonal catabolism. A negative feedback signal may exist between hepatic sensitivity to glucagon and the secretion of this hormone.

Adult

[Late results (10 years) after complete arterialization of the cirrhotic liver].

The authors present the results obtained after 10 years in two patients with hepatic cirrhosis in whom arterialization was carried out, of the liver, in association with a portocaval, or as an isolated intervention. These 2 cases represent the longest post-operative follow-ups of a group of 29 patients in whom hepatic arterilization was performed. The authors have used an original procedure of arterialization through the re-permeabilized ombilical vein. In the paper are given indications on the method on the basis of the experience acquired between 1965 and 1976.

Adult

Portacaval shunt with arterialization of the portal vein by means of a low flow arteriovenous fistula.

A new operative technique was designed combining an end-to-side portacaval shunt with arterialization of the intrahepatic portal vein by means of a saphenous vein graft between the right gastroepiploic artery and the stump of the portal vein. The objective of this operation is to perfuse the hepatic portion of the portal vein with a low volume of arterial blood to ameliorate the adverse metabolic consequences of portosystemic decompression. The procedure was performed upon 18 patients with one operative mortality. The mean follow-up period is 15.4 months. The benefits of this operation are evident in the prevention of hepatic decompensation and avoidance of encephalophy, thus permiting unrestricted protein intake. The operation is well tolerated, and the operative mortality appears to be less than that following conventional shunting procedures.

Adult

[Splenic artery ligature and latero-lateral anastomosis in portal hypertension (author's transl)].

A new type of shunt for decompressing portal hypertension is described, consisting of ligation of the spleno-renal anastomosis. This reduces the pressure in the portal territory and in the dangerous gastric and oesophageal varices. In addition the procedure also abolishes the marrow inhibition due to splenic activity without removing the spleen and maintaining part of the portal circulation. The advantages and disadvantages of various decompression operations are discussed and compared with other methods in current use.

Arteriovenous Shunt, Surgical

Arterialization of the portal vein in cirrhosis: the findings at celiac arteriography.

An angiographic study of a new operation for portal hypertension involving arterialization of the portal vein in combination with an end-to-side portacaval shunt is described. The angiographic appearances differ from those of end-to-side shunts alone. With the new operation there is, in particular, no significant change in the wedge pressure or in the hepatic artery size from preoperative to postoperative studies, and in the majority of patients, the liver size is also unchanged. The incidence of porto-systemic shunting from the portal vein to the low pressure caval system (66%) is lower than for end-to-side shunts alone. Changes are seen in the distal portal bed in the majority of cases.

Arteriovenous Shunt, Surgical

Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.

The change in plasma cyclic adenosine-3', 5'-monophosphate (AMP) was measured after intravenous injection of 1 mg of glucagon in 10 normal subjects and 30 patients with various forms of liver disease. Patients with cirrhosis and those with intrahepatic cholestasis responded normally but in patients with extrahepatic obstruction the plasma cyclic AMP response was considerably increased. Six of the eight patients with cirrhosis and a surgically created portacaval shunt had very reduced responses. This test may prove to be diagnostically important, particularly in differentiating surgical from non-surgical jaundice.

Blood Glucose

Bilharzial portal fibrosis: an important cause of portal hypertension.

Thirty consecutive cases of portal hypertension seen in a surgical unit in Lusaka, Zambia, are reported. Of these cases 70% were due to portal fibrosis caused by Schistosoma mansoni infestation. Portacaval shunting was undertaken in most cases. Patients with portal fibrosis responded more favourably to portal decompression than did patients with cirrhosis. It is probable that the condition is more common than is generally reconigzed in areas where S. mansoni infestation is endemic.

Adolescent

[The use of vasopressin during portal bypass (author's transl)].

Vasopressin was infused intra-arterially or intravenously during 12 portal bypass operations. In comparison with a control group (without vasopressin), there was a very significant reduction in blood loss and portal pressure, and a moderate increase in arterial blood pressure.

Blood Pressure